FDA’s first ‘modified risk’ tobacco products set precedent
They could set the standard for vaping products.
Regulatory
Timeline: Pharma navigates the first federal opioid trial
The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits.
Last-minute settlements delay Ohio opioid trial
Three drug distributors and a pharma company reached deals to avoid going to trial Monday.
Healthcare moments from Tuesday’s Democratic debate
Healthcare-related topics included tax increases under Medicare For All and holding pharma accountable for the opioid epidemic.
Opioid crisis education: The key to fixing pharma’s political and reputation problems?
As the opioid crisis continues to wreak havoc across the country, experts believe education may be the key to fixing pharma’s political and reputation problems.
CDC official stresses urgency of investigating vaping to Congress
The CDC’s principal deputy director said “hundreds” of new lung illness cases have been reported since last week.
What 5 states have done on vaping in one week
In the week since the Trump administration proposed banning flavored e-cigarettes, five states have taken action of their own.
What an 11-figure settlement could mean for Purdue Pharma
The lawsuits are set to go to trial next month.
Juul’s new marketing strategy doesn’t hold up to FDA scrutiny
The FDA sent its first warning letter to Juul after months of efforts to crack down on the company’s marketing tactics.
What politics has done to the healthcare industry’s reputation
The pharma industry fell dead last in Gallup’s latest industry reputation survey.
Want to read more?
Please login or register first to view this content.
